PubMed

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articles

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

[Prevalence of type II diabetes mellitus in population of Krakow]

Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W.

Pol Arch Med Wewn. 2001 Sep;106(3):771-9. Polish. PMID: 11928585 [PubMed - indexed for MEDLINE]Related articles

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group.

J Pediatr. 2007 Jan;150(1):31-36.e6.PMID: 17188609 [PubMed - indexed for MEDLINE]Related articlesFree article

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group.

Diabetes. 2001 Feb;50(2):470-6.PMID: 11272162 [PubMed - indexed for MEDLINE]Related articlesFree article

Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

Motala AA, Omar MA, Gouws E.

Diabetes Care. 1997 Jul;20(7):1101-7.PMID: 9203444 [PubMed - indexed for MEDLINE]Related articles

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Triolo TM, Chase HP, Barker JM; DPT-1 Study Group.

Diabetes Care. 2009 May;32(5):769-73.PMID: 19407074 [PubMed - indexed for MEDLINE]Related articlesFree article

Dysglycemia and a history of reproductive risk factors.

McDonald SD, Yusuf S, Sheridan P, Anand SS, Gerstein HC; Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Trial Investigators.

Diabetes Care. 2008 Aug;31(8):1635-8. Epub 2008 May 5.PMID: 18458144 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.PMID: 9702423 [PubMed - indexed for MEDLINE]Related articlesFree article

High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance.

Yoshinaga H, Kosaka K.

Diabetes Res Clin Pract. 1996 Mar;31(1-3):71-9.PMID: 8792104 [PubMed - indexed for MEDLINE]Related articles

Fasting proinsulin concentrations predict the development of type 2 diabetes.

Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.

Diabetes Care. 1999 Feb;22(2):262-70.PMID: 10333943 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention.

Osei K, Rhinesmith S, Gaillard T, Schuster D.

Diabetes Care. 2004 Jun;27(6):1439-46.PMID: 15161801 [PubMed - indexed for MEDLINE]Related articlesFree article

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.PMID: 11755481 [PubMed - indexed for MEDLINE]Related articles

Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study.

Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M; Bruneck study.

Diabetes. 2004 Jul;53(7):1782-9.PMID: 15220202 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

JAMA. 2001 Apr 25;285(16):2109-13.PMID: 11311100 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of changes in glucose tolerance status in obese youth.

Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S.

Diabetes Care. 2005 Apr;28(4):902-9.PMID: 15793193 [PubMed - indexed for MEDLINE]Related articlesFree article